VivoSim Labs, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2013-01-04: Federal exemption Rule 506; Types of securities offered SecurityToBeAcquired; Date of first sale 2012-12-21; Total offering amount $7,662,675.
- 2012-02-29: Federal exemption Rule 506; Types of securities offered Equity; OptionToAcquire; Date of first sale 2012-02-08; Total offering amount $16,000,000.
- 2012-02-07: Federal exemption Rule 506; Types of securities offered Equity; OptionToAcquire; Date of first sale Yet to occur; Total offering amount $8,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2013-01-04 | Rule 506 | SecurityToBeAcquired | 2012-12-21 | $7,662,675 | $7,662,675 | $0 | 109 |
| 2012-02-29 D/A | Rule 506 | Equity; OptionToAcquire | 2012-02-08 | $16,000,000 | $8,331,977 | $7,668,023 | 119 |
| 2012-02-07 | Rule 506 | Equity; OptionToAcquire | Yet to occur | $8,000,000 | $0 | $8,000,000 | 0 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |